This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John F. Pezzimenti, MD; Andrew L. Hahn, MD

Arch Intern Med. 1970;125(1):118-120.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Diphenylhydantoin has been widely used as an anticonvulsant since its introduction by Merritt and Putnam ¹ in 1938. While the drug is well tolerated by the majority of patients, it can produce a great variety of toxic and allergic reactions.² During the first several weeks of therapy, a skin rash occurs in about 5% of patients.³ Usually this eruption is erythematous or morbilliform, is not accompanied by systemic symptoms, and does not necessitate permanent discontinuation of therapy. Occasionally, however, a more severe reaction occurs, with a pleomorphic, often exfoliative rash and high fever; hepatitis may be an associated finding.

To our knowledge, the patient described here is the tenth patient reported to have had acute hepatitis accompanying the diphenylhydantoin reaction of fever and skin rash.

Patient Summary

A 19-year-old Negro male was admitted to Douglas County Hospital on Dec 11, 1966, after his second grand mal seizure, the . . . [Full Text PDF of this Article]

Author Affiliations
Omaha

From the Department of Medicine, Creighton University School of Medicine, Omaha.

Footnotes
Received for publication Jan 14, 1969; accepted Feb 14.

Reprint requests to 2305 S 10th St, Omaha 68108 (Dr. Hahn).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?